@article{fdi:010077380,
  title = {{I}mpact of the 2017 {A}merican {A}cademy of {P}ediatrics {G}uideline on {H}ypertension {P}revalence compared with the {F}ourth {R}eport in an {I}nternational {C}ohort},
  author = {{Y}ang, {L}. and {K}elishadi, {R}. and {H}ong, {Y}. {M}. and {K}hadilkar, {A}. and {N}awarycz, {T}. and {K}rzywinska-{W}iewiorowska, {M}. and {A}ounallah-{S}khiri, {H}. and {M}otlagh, {M}. {E}. and {K}im, {H}. {S}. and {K}hadilkar, {V}. and {K}rzyzaniak, {A}. and {B}en {R}omdhane, {H}. and {H}eshmat, {R}. and {C}hiplonkar, {S}. and {S}tawinska-{W}itoszynska, {B}. and {E}l {A}ti, {J}. and {Q}orbani, {M}. and {K}ajale, {N}. and {T}raissac, {P}ierre and {O}strowska-{N}awarycz, {L}. and {A}rdalan, {G}. and {E}kbote, {V}. and {Z}hao, {M}. and {H}eiland, {E}. {G}. and {L}iang, {Y}. {J}. and {X}i, {B}.},
  editor = {},
  language = {{ENG}},
  abstract = {{I}n 2017, the {A}merican {A}cademy of {P}ediatrics ({AAP}) updated the clinical practice guideline for high blood pressure ({BP}) in the pediatric population. {I}n this study, we compared the difference in prevalence of elevated and hypertensive {BP} values defined by the 2017 {AAP} guideline and the 2004 {F}ourth {R}eport and estimated the cardiovascular risk associated with the reclassification of {BP} status defined by the {AAP} guideline. {A} total of 47 200 children and adolescents aged 6 to 17 years from 6 countries ({C}hina, {I}ndia, {I}ran, {K}orea, {P}oland, and {T}unisia) were included in this study. {E}levated {BP} and hypertension were defined according to 2 guidelines. {I}n addition, 1606 children from {C}hina, {I}ran, and {K}orea who were reclassified upward by the {AAP} guideline compared with the {F}ourth {R}eport and for whom laboratory data were available were 1:1 matched with children from the same countries who were normotensive by both guidelines. {C}ompared with the {F}ourth {R}eport, the prevalence of elevated {BP} defined by the {AAP} guideline was lower (14.9% versus 8.6%), whereas the prevalence of stages 1 and 2 hypertension was higher (stage 1, 6.6% versus 14.5%; stage 2, 0.4% versus 1.7%). {A}dditionally, comparison of laboratory data in the case-control study showed that children who were reclassified upward were more likely to have adverse lipid profiles and high fasting blood glucose compared with normotensive children. {I}n conclusion, the prevalence of elevated {BP} and hypertension varied significantly between both guidelines. {A}pplying the new {AAP} guideline could identify more children with hypertension who are at increased cardiovascular risk.},
  keywords = {blood pressure ; child ; hypertension ; pediatrics ; {CHINE} ; {INDE} ; {IRAN} ; {COREE} ; {POLOGNE} ; {TUNISIE}},
  booktitle = {},
  journal = {{H}ypertension},
  volume = {74},
  numero = {6},
  pages = {1343--1348},
  ISSN = {0194-911{X}},
  year = {2019},
  DOI = {10.1161/hypertensionaha.119.13807},
  URL = {https://www.documentation.ird.fr/hor/fdi:010077380},
}